Green, D <br/><br/>
Preclinical evaluation of WR-151327: an orally active chemotherapy protector.  [electronic resource] 

 -  Cancer research  Feb 1994 
 - 738-41 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Amifostine--pharmacology<br/>Animals<br/>Antineoplastic Agents--toxicity<br/>Bone Marrow--drug effects<br/>Bone Marrow Cells<br/>Bone Marrow Diseases--chemically induced<br/>Dose-Response Relationship, Drug<br/>Drug Screening Assays, Antitumor<br/>Female<br/>Hematopoietic Stem Cells--drug effects<br/>Injections, Intraperitoneal<br/>Leukemia P388--drug therapy<br/>Leukocytes--drug effects<br/>Leukopenia--chemically induced<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred DBA<br/>Neoplasm Transplantation<br/>Organothiophosphorus Compounds--pharmacology<br/>Radiation-Protective Agents--pharmacology